Indonesia Probes Palm Oil Giants for Alleged UnderInvoicing Practices BlackBerry Leverages Malaysia as Strategic Hub to Expand Cybersecurity Operations in Asia Bitcoin Approaches 75K as Golden Cross Formation Captures Trader Attention Zcash Falls 9 Traders Bet on Nifty 16 Swing by Tuesday Using Long Straddle Amid West Asia Tensions Pfizer Prevails in Singapore Trademark Dispute with Merck Over Vaccine Brand Intercontinental Exchange to Launch GPU Compute Futures Suite Targeting Transparency in AI Infrastructure Costs ARDT Q1 2026 Earnings EPS Surges Past Estimates with 486 Beat HTFC Q1 2026 Earnings Narrow EPS Miss Amid Stable Operations FCX Q1 2026 Earnings Strong Earnings Beat Amid Robust Copper Demand ADMA Biologics Q1 2026 Earnings EPS Misses Estimates Amid Stock Downdraft ELV Q1 2026 Earnings Strong Earnings Beat Overshadowed by Stock Decline Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress Maison Solutions Inc MSS Stock Hovers Near Key Support Amid Modest Uptick Lamar Advertising LAMR Edges Higher as Investors Eye Key Resistance Level Agriculture Natural Solutions Acquisition Corporation ANSC Holds Steady at 1136 Trading Within Established Range Armada Acquisition Corp II Warrant XRPNW Surges 14 Amid Speculative Trading High Income Securities Fund PCF Holds Steady Near Support Amid Low Volatility India Captures Data Center Growth Despite Limited Direct AI Chip Sector Exposure SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Circle Internet Group CRCL Finds Demand at Support Closing Near Session Highs First Mid Bancshares Holds Near Support Amid Modest Pullback American Resources Corporation AREC Edges Higher as Stock Tests Support Levels Dogness DOGZ Hovers Near Support After Slight Decline Resistance at 109 in Focus ARB IOT Group ARBB Holds Near 503 as Narrow Trading Range Persists Univest Financial UVSP Slides 113 as Regional Banking Sector Faces Headwinds FACT II Acquisition Corp Warrant FACTW Slides 37 as Warrants Approach Key Support TransCode Therapeutics RNAZ Drops 1066 Support at 53 Faces Critical Test After Sharp Decline